Evidence map›Paper›PMID 26000632›Full record

ArticlePloS one2015

Automated axial right ventricle to left ventricle diameter ratio computation in computed tomography pulmonary angiography.

Germán González, Daniel Jiménez-Carretero, Sara Rodríguez-López, Kanako K Kumamaru, Elizabeth George, Raúl San José Estépar, Frank J Rybicki, Maria J Ledesma-Carbayo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Germán GonzálezMadrid-MIT M+Visión Consortium, Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Surgical Planning Laboratory, Brigham and Women´s Hospital, Boston, Massachusetts, United States of America.
Daniel Jiménez-CarreteroBiomedical Image Technologies, Universidad Politécnica de Madrid & CIBER-BBN, Madrid, Spain.
Sara Rodríguez-LópezBiomedical Image Technologies, Universidad Politécnica de Madrid & CIBER-BBN, Madrid, Spain.
Kanako K KumamaruApplied Imaging Science Laboratory, Brigham and Women´s Hospital, Boston, Massachusetts, United States of America.
Elizabeth GeorgeApplied Imaging Science Laboratory, Brigham and Women´s Hospital, Boston, Massachusetts, United States of America.
Raúl San José EstéparSurgical Planning Laboratory, Brigham and Women´s Hospital, Boston, Massachusetts, United States of America.
Frank J RybickiApplied Imaging Science Laboratory, Brigham and Women´s Hospital, Boston, Massachusetts, United States of America.
Maria J Ledesma-CarbayoBiomedical Image Technologies, Universidad Politécnica de Madrid & CIBER-BBN, Madrid, Spain.
Brigham and Women's Hospital · USBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESMassachusetts Institute of Technology · USUniversidad Politécnica de Madrid · ES

Funding

Airway Inspector: a chest imaging biomarker software platform for COPDR01HL116931 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAN JOSE ESTEPAR, RAUL · 2013 to 2017
$2.2M
NHLBI NIH HHS R01 HL116931
6 · The paper itself

Abstract

background and purposeRight Ventricular to Left Ventricular (RV/LV) diameter ratio has been shown to be a prognostic biomarker for patients suffering from acute Pulmonary Embolism (PE). While Computed Tomography Pulmonary Angiography (CTPA) images used to confirm a clinical suspicion of PE do include information of the heart, a numerical RV/LV diameter ratio is not universally reported, likely because of lack in training, inter-reader variability in the measurements, and additional effort by the radiologist. This study designs and validates a completely automated Computer Aided Detection (CAD) system to compute the axial RV/LV diameter ratio from CTPA images so that the RV/LV diameter ratio can be a more objective metric that is consistently reported in patients for whom CTPA diagnoses PE. MATERIALS AND

methodsThe CAD system was designed specifically for RV/LV measurements. The system was tested in 198 consecutive CTPA patients with acute PE. Its accuracy was evaluated using reference standard RV/LV radiologist measurements and its prognostic value was established for 30-day PE-specific mortality and a composite outcome of 30-day PE-specific mortality or the need for intensive therapies. The study was Institutional Review Board (IRB) approved and HIPAA compliant.

resultsThe CAD system analyzed correctly 92.4% (183/198) of CTPA studies. The mean difference between automated and manually computed axial RV/LV ratios was 0.03±0.22. The correlation between the RV/LV diameter ratio obtained by the CAD system and that obtained by the radiologist was high (r=0.81). Compared to the radiologist, the CAD system equally achieved high accuracy for the composite outcome, with areas under the receiver operating characteristic curves of 0.75 vs. 0.78. Similar results were found for 30-days PE-specific mortality, with areas under the curve of 0.72 vs. 0.75.

conclusionsAn automated CAD system for determining the CT derived RV/LV diameter ratio in patients with acute PE has high accuracy when compared to manual measurements and similar prognostic significance for two clinical outcomes.

Indexed as

AdultAgedAged, 80 and overAngiographyFemaleHeart VentriclesHumansLungMaleMiddle AgedPredictive Value of TestsPrognosisPulmonary EmbolismReproducibility of ResultsSensitivity and SpecificityTomography, X-Ray Computed

Identifiers

PMID26000632
PMCPMC4441508
OpenAlexW1648431896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.